These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24962756)

  • 1. Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups.
    Nunes B; Machado A; Guiomar R; Pechirra P; Conde P; Cristovão P; Falcão I
    Vaccine; 2014 Jul; 32(35):4443-4449. PubMed ID: 24962756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.
    Savulescu C; Jiménez-Jorge S; Delgado-Sanz C; de Mateo S; Pozo F; Casas I; Larrauri A;
    Vaccine; 2014 Jul; 32(35):4404-4411. PubMed ID: 24968153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.
    van Doorn E; Darvishian M; Dijkstra F; Donker GA; Overduin P; Meijer A; Hak E
    Vaccine; 2017 May; 35(21):2831-2839. PubMed ID: 28412077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.
    Valenciano M; Kissling E; Cohen JM; Oroszi B; Barret AS; Rizzo C; Nunes B; Pitigoi D; Larrauri Cámara A; Mosnier A; Horvath JK; O'Donnell J; Bella A; Guiomar R; Lupulescu E; Savulescu C; Ciancio BC; Kramarz P; Moren A
    PLoS Med; 2011 Jan; 8(1):e1000388. PubMed ID: 21379316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe.
    Kissling E; Valenciano M; Cohen JM; Oroszi B; Barret AS; Rizzo C; Stefanoff P; Nunes B; Pitigoi D; Larrauri A; Daviaud I; Horvath JK; O'Donnell J; Seyler T; Paradowska-Stankiewicz IA; Pechirra P; Ivanciuc AE; Jiménez-Jorge S; Savulescu C; Ciancio BC; Moren A
    PLoS One; 2011; 6(11):e27622. PubMed ID: 22110695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method.
    Vilcu AM; Souty C; Enouf V; Capai L; Turbelin C; Masse S; Behillil S; Valette M; Guerrisi C; Rossignol L; Blanchon T; Lina B; Hanslik T; Falchi A
    Clin Microbiol Infect; 2018 Apr; 24(4):431.e5-431.e12. PubMed ID: 28899840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan.
    Saito N; Komori K; Suzuki M; Morimoto K; Kishikawa T; Yasaka T; Ariyoshi K
    Vaccine; 2017 Jan; 35(4):687-693. PubMed ID: 28043738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.
    Jiménez-Jorge S; Savulescu C; Pozo F; de Mateo S; Casas I; Ledesma J; Larrauri A; ;
    Vaccine; 2012 May; 30(24):3595-602. PubMed ID: 22472792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A
    Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies.
    Young B; Sadarangani S; Jiang L; Wilder-Smith A; Chen MI
    J Infect Dis; 2018 Feb; 217(5):731-741. PubMed ID: 29220496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study.
    Kafatos G; Pebody R; Andrews N; Durnall H; Barley M; Fleming D
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1175-80. PubMed ID: 24103037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States.
    Cowling BJ; Feng S; Finelli L; Steffens A; Fowlkes A
    Vaccine; 2016 Jan; 34(1):61-6. PubMed ID: 26611200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
    Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The case test-negative design for studies of the effectiveness of influenza vaccine.
    Foppa IM; Haber M; Ferdinands JM; Shay DK
    Vaccine; 2013 Jun; 31(30):3104-9. PubMed ID: 23624093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
    Maurel M; Mazagatos C; Goerlitz L; Oroszi B; Hooiveld M; Machado A; Domegan L; Ilić M; Popescu R; Sève N; Martínez-Baz I; Larrauri A; Buda S; Túri G; Meijer A; Gomez V; O'Donnell J; Mlinarić I; Timnea O; Diez AO; Dürrwald R; Horváth JK; Dijkstra F; Rodrigues AP; McKenna A; Filipović SK; Lazar M; Kaczmarek M; Bacci S; Kissling E;
    Vaccine; 2024 Jun; 42(16):3547-3554. PubMed ID: 38704257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.